Search - tctmd.com

Displaying 1 - 20 of 109

Sort: Relevancy | Date

$Role of fracture during valve in valve - When and How to do?$

Presentation TCT India 2025

Role of fracture during valve in valve - When and How to do?

Presenter: Susheel Kodali

July 25, 2025

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

Presentation TCT 2024

How to Manage After TTVI?

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 30, 2024

Presentation TCT 2024

Role of Advanced Imaging Guidance by AI-Based Device Intelligence

Presenter: Susheel Kodali

October 29, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

TRISCEND II: Understanding the Study Design and Interpreting the Results

Presenter: Susheel K. Kodali

June 06, 2024

Presentation NY Valves 2024

Clinical Results with the DurAVR THV System

Presenter: Susheel K. Kodali

June 05, 2024

Presentation THT 2024

Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel

Presenter: Susheel K. Kodali

March 04, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

Presentation TCT 2023

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

Orthotopic TTVR: What Have We Learned From the EFS studies

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Presenter: Susheel Kodali

October 26, 2023

Presentation TCT 2023

Prevention and Management of Coronary Obstruction in VIV-TAVR

Presenter: Susheel Kodali

October 25, 2023

Presentation TCT 2023

ShortCut(TM) Pivotal Study Update: Dedicated Transcatheter Leaflet Splitting Device

Presenter: Susheel Kodali

October 23, 2023

Presentation Fellows 2023

The Structural Heart Revolution: Perspectives From Fellowship and Beyond

Presenter: Susheel Kodali

May 13, 2023

News Conference News PCR London Valves 2022

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

Shelley Wood

November 28, 2022

Presentation TCT 2022

ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)

Presenter: Susheel K. Kodali

September 18, 2022

Advertisement

Role of fracture during valve in valve - When and How to do?

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

How to Manage After TTVI?

TRISCEND II Trial: Transcatheter Valve Replacement vs. Optimal Medical Therapy for Severe Tricuspid Regurgitation

Role of Advanced Imaging Guidance by AI-Based Device Intelligence

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Report of an IDE Pivotal Study of a Dedicated Leaflet Splitting Device During TAVR (SHORTCUT)

TRISCEND II: Understanding the Study Design and Interpreting the Results

Clinical Results with the DurAVR THV System

Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Review of the Current Clinical Evidence for Transcatheter Tricuspid Valve Therapies

Orthotopic TTVR: What Have We Learned From the EFS studies

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Prevention and Management of Coronary Obstruction in VIV-TAVR

ShortCut(TM) Pivotal Study Update: Dedicated Transcatheter Leaflet Splitting Device

The Structural Heart Revolution: Perspectives From Fellowship and Beyond

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content